£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days · 90 data points

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 25 August 2026 16 September 2026 08 October 2026 31 October 2026
View at Amazon ↗

Price data checked 1 day ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 90 days • 1 price levels

Days at Price
90 days 0 23 45 68 90 £490 Days at Price

Price Analysis

Most common price: £490 (90 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 90 days

Description

This statistical study provides a comprehensive outlook for HER-2 positive breast cancer chemotherapy across the United States from 2023 to 2028. The report details latent demand, also known as potential industry earnings (P.I.E.), across 10,833 US zip codes. By providing specific estimates in millions of U.S. dollars, this data allows for precise market analysis at a local level. Users can access comparative benchmarks for each zip code, including its percent share of its respective state and the United States as a whole. This granular approach helps professionals gauge specific zip codes against others, making it a useful tool for managing distribution strategies and optimizing sales force deployment.

Key Features

Provides latent demand estimates in millions of U.S. dollars for HER-2 positive breast cancer chemotherapy.

Covers 10,833 specific US zip codes to offer localized market data for industry analysis.

Includes percent share data for each zip code relative to its state and the entire United States.

Offers comparative benchmarks to help gauge the value of one zip code against others.

Serves as a statistical resource for improving distribution and sales force planning.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China

£495.00 31 Oct 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

£495.00 15 Aug 2026
Breast Cancer Diagnostic Products Outlook 2023-2028 Report
99% match

Breast Cancer Diagnostic Products Outlook 2023-2028 Report

£490.00 20 Aug 2026
2023-2028 US Breast Cancer Screening Outlook by Zip Code
98% match

2023-2028 US Breast Cancer Screening Outlook by Zip Code

£490.00 19 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 03 Oct 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India
98% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India

£515.00 22 Aug 2026
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
98% match

HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028

£520.00 19 Aug 2026
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
98% match

The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

Price unavailable
The 2023-2028 Outlook for Breast Cancer Screenings in China
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 15 Aug 2026
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in Japan

£495.00 19 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 26 Sep 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 02 Oct 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 15 Aug 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
97% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
97% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India

£515.00 20 Aug 2026
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
97% match

The 2025-2030 World Outlook for Breast Cancer Diagnostic Products

Price unavailable
The 2025-2030 World Outlook for Breast Cancer Screenings
97% match

The 2025-2030 World Outlook for Breast Cancer Screenings

Price unavailable
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 01 Oct 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
97% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 16 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 02 Oct 2026
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
97% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 26 Sep 2026
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
97% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 02 Oct 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
97% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026